TITLE

Genomic instability of human embryonic stem cell lines using different passaging culture methods

AUTHOR(S)
Tosca, Lucie; Feraud, Olivier; Magniez, Aurélie; Bas, Cécile; Griscelli, Frank; Bennaceur-Griscelli, Annelise; Tachdjian, Gérard
PUB. DATE
June 2015
SOURCE
Molecular Cytogenetics (17558166);2015, Vol. 8 Issue 1, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Human embryonic stem cells exhibit genomic instability that can be related to culture duration or to the passaging methods used for cell dissociation. In order to study the impact of cell dissociation techniques on human embryonic stem cells genomic instability, we cultured H1 and H9 human embryonic stem cells lines using mechanical/manual or enzymatic/collagenase-IV dissociation methods. Genomic instability was evaluated at early (p60) passages by using oligonucleotide based array-comparative genomic hybridization 105 K with a mean resolution of 50 Kb. Results: DNA variations were mainly located on subtelomeric and pericentromeric regions with sizes <100 Kb. In this study, 9 recurrent genomic variations were acquired during culture including the well known duplication 20q11.21. When comparing cell dissociation methods, we found no significant differences between DNA variations number and size, DNA gain or DNA loss frequencies, homozygous loss frequencies and no significant difference on the content of genes involved in development, cell cycle tumorigenesis and syndrome disease. In addition, we have never found any malignant tissue in 4 different teratoma representative of the two independent stem cell lines. Conclusions: These results show that the occurrence of genomic instability in human embryonic stem cells is similar using mechanical or collagenase IV-based enzymatic cell culture dissociation methods. All the observed genomic variations have no impact on the development of malignancy.
ACCESSION #
108307214

 

Related Articles

  • New Human Embryonic Stem-Cell Lines to Be Made Available to Researchers.  // Ascribe Newswire: Medicine;3/4/2004, p20 

    Howard Hughes Medical Institute researchers at Harvard University announced today that they have derived 17 new human embryonic stem-cell lines. The new cell lines will be made available to researchers, although at this time United States policies prohibit the use of federal funds to investigate...

  • Feeding hungry stem cells. Pedersen, Roger A. // Nature Biotechnology;Sep2002, Vol. 20 Issue 9, p882 

    Reports on research by M. Richards and colleagues demonstrating that two pre-existing human embryonic stem (HES) cell lines retained their undifferentiated state when cultured with human fetal fibroblasts. Theoretical and practical challenges posed by the dependence of HES cells on any feeder...

  • Agouti C57BL/6N embryonic stem cells for mouse genetic resources. Pettitt, Stephen J.; Qi Liang; Rairdan, Xin Y.; Moran, Jennifer L.; Prosser, Haydn M.; Beier, David R.; Lloyd, Kent C.; Bradley, Allan; Skarnes, William C. // Nature Methods;Jul2009, Vol. 6 Issue 7, p493 

    We report the characterization of a highly germline competent C57BL/6N mouse embryonic stem cell line, JM8. To simplify breeding schemes, the dominant agouti coat color gene was restored in JM8 cells by targeted repair of the C57BL/6 nonagouti mutation. These cells provide a robust foundation...

  • Uniform stable-isotope labeling in mammalian cells: formulation of a cost-effective culture medium. Egorova-Zachernyuk, Tatiana A.; Bosman, Giel J. C. G. M.; DeGrip, Willem J. // Applied Microbiology & Biotechnology;Jan2011, Vol. 89 Issue 2, p397 

    Uniform stable-isotope labeling of mammalian cells is achieved via a novel formulation of a serum-free cell culture medium that is based on stable-isotope-labeled autolysates and lipid extracts of various microbiological origin. Yeast autolysates allow complete replacement of individual amino...

  • Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency. Hotta, Akitsu; Cheung, Aaron Y. L.; Farra, Natalie; Vijayaragavan, Kausalia; Séguin, Cheryle A.; Draper, Jonathan S.; Pasceri, Peter; Maksakova, Irina A.; Mager, Dixie L.; Rossant, Janet; Bhatia, Mickie; Ellis, James // Nature Methods;May2009, Vol. 6 Issue 5, p370 

    Induced pluripotent stem (iPS) cells may be of use in regenerative medicine. However, the low efficiency of reprogramming is a major impediment to the generation of patient-specific iPS cell lines. Here we report the first selection system for the isolation of human iPS cells. We developed the...

  • Novel lines of Pax6-I- embryonic stem cells exhibit reduced neurogenic capacity without loss of viability. Quinn, Jane C; Molinek, Michael; Nowakowski, Tomasz J.; Mason, John O.; Price, David J. // BMC Neuroscience;2010, Vol. 11, p26 

    Background: Embryonic stem (ES) cells can differentiate into all cell types and have been used extensively to study factors affecting neuronal differentiation. ES cells containing mutations in known genes have the potential to provide useful in vitro models for the study of gene function during...

  • Dynamic expression patterns of imprinted genes in human embryonic stem cells following prolonged passaging and differentiation. Mai, Xiuyun; Mai, Qingyun; Li, Tao; Zhou, Canquan // Journal of Assisted Reproduction & Genetics;Apr2011, Vol. 28 Issue 4, p315 

    Purpose: To evaluate the overall expression patterns of imprinted genes in human embryonic stem cells following long term culture and differentiation. Materials and methods: Expression levels of 65 imprinted genes determined by PCR array were analyzed in one human embryonic stem cell line...

  • Embryonic Stem Cells: Overcoming the Immunological Barriers to Cell Replacement Therapy. Lui, Kathy O.; Waldmann, Herman; Fairchild, Paul J. // Current Stem Cell Research & Therapy;Jan2009, Vol. 4 Issue 1, p70 

    The appeal of using embryonic stem (ES) cells for regenerative medicine lies in their pluripotency and resulting ability to differentiate into all somatic cell types. While graft rejection remains the greatest hurdle to their use in the clinic, several approaches have been proposed to protect...

  • New Human Embryonic Stem-Cell Lines to Be Made Available to Researchers.  // Ascribe Newswire: Medicine;3/3/2004, p20 

    Howard Hughes Medical Institute researchers at Harvard University announced today that they have derived 17 new human embryonic stem-cell lines. The new cell lines will be made available to researchers, although at this time United States policies prohibit the use of federal funds to investigate...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics